Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations

Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2009-04, Vol.236 (1), p.71-77
Hauptverfasser: Yamada, Shigeyuki, Zhang, Xiu Quan, Kadono, Toshie, Matsuoka, Nobuhiro, Rollins, Douglas, Badger, Troy, Rodesch, Christopher K., Barry, William H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 77
container_issue 1
container_start_page 71
container_title Toxicology and applied pharmacology
container_volume 236
creator Yamada, Shigeyuki
Zhang, Xiu Quan
Kadono, Toshie
Matsuoka, Nobuhiro
Rollins, Douglas
Badger, Troy
Rodesch, Christopher K.
Barry, William H.
description Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca 2+] i was measured by flow cytometry using fluo-3. Mitochondrial [Ca 2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy. CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca 2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca 2+] i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca 2+] i during P-MI was also prevented by ranolazine. CSE in clinically relevant concentrations increases myocyte [Ca 2+] i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.
doi_str_mv 10.1016/j.taap.2009.01.008
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21182769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X09000283</els_id><sourcerecordid>20433719</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</originalsourceid><addsrcrecordid>eNp9kU-P1DAMxSMEYoeFL8ABRUJw6-Ak3TaVuKDlr7QSF5C4RW7qQoa2GZLMaufb4zIjuHGKYv9s-b0nxFMFWwWqebXbFsT9VgN0W1BbAHtPbBR0TQXGmPtiA1CrisvfLsSjnHfAYF2rh-JCdaZVjVYbUd6GRL7IEu-ClzSO_MkyjhJ_HSgesqS7kpABLvnwHROVQjLP8SfJuEiPaQjo5XyM_lgoSyzST2EJHqfpKBNNdIsL1-LiaeFNJcQlPxYPRpwyPTm_l-Lr-3dfrj9WN58_fLp-c1P5ujalavrGeAW6B7JDra9so3rTtzg0Q4saWm7Z3htrx2646tvOAnYw1oNF6g2a1lyK56e9MZfgsg-F_A8-ZWGRTitlddt0TL08UfsUWXQubg7Z0zThsjrgNNSG7VpBfQJ9ijknGt0-hRnT0SlwayJu59ZE3JqIA-XYeh56dt5-6Gca_o2cI2DgxRnAzK6NCRcf8l9OK911tl251yeO2LHbQGkVRGzr8CdBN8Twvzt-A22nqvQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20433719</pqid></control><display><type>article</type><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</creator><creatorcontrib>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</creatorcontrib><description>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca 2+] i was measured by flow cytometry using fluo-3. Mitochondrial [Ca 2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy. CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca 2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca 2+] i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca 2+] i during P-MI was also prevented by ranolazine. CSE in clinically relevant concentrations increases myocyte [Ca 2+] i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2009.01.008</identifier><identifier>PMID: 19371621</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology ; 60 APPLIED LIFE SCIENCES ; Acetanilides - pharmacology ; Angina Pectoris - etiology ; Angina Pectoris - metabolism ; Animals ; Biological and medical sciences ; CALCIUM ; Calcium - metabolism ; CALCIUM IONS ; CARBON NITRIDES ; Cells, Cultured ; Cigarette smoke ; CYANIDES ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; FLUORESCENCE ; Free Radical Scavengers - pharmacology ; GLUCOSE ; Glucose - metabolism ; Heart Ventricles - drug effects ; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ; ISCHEMIA ; Medical sciences ; MICE ; MITOCHONDRIA ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondrial Membrane Transport Proteins - drug effects ; Mitochondrial Membrane Transport Proteins - metabolism ; Myocardial Contraction - drug effects ; Myocardial Infarction - etiology ; Myocardial Infarction - physiopathology ; Myocardial Ischemia - complications ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - physiopathology ; Myocyte ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; NICOTINE ; Nicotine - analysis ; OXIDATION ; Piperazines - pharmacology ; RABBITS ; Ranolazine ; Reactive Oxygen Species - metabolism ; Smoke - adverse effects ; Smoke - analysis ; Smoking - adverse effects ; Time Factors ; TIRON ; TOBACCO SMOKES ; Tobacco, tobacco smoking ; TOXICITY ; Toxicology</subject><ispartof>Toxicology and applied pharmacology, 2009-04, Vol.236 (1), p.71-77</ispartof><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</citedby><cites>FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X09000283$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21299871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19371621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21182769$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Shigeyuki</creatorcontrib><creatorcontrib>Zhang, Xiu Quan</creatorcontrib><creatorcontrib>Kadono, Toshie</creatorcontrib><creatorcontrib>Matsuoka, Nobuhiro</creatorcontrib><creatorcontrib>Rollins, Douglas</creatorcontrib><creatorcontrib>Badger, Troy</creatorcontrib><creatorcontrib>Rodesch, Christopher K.</creatorcontrib><creatorcontrib>Barry, William H.</creatorcontrib><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca 2+] i was measured by flow cytometry using fluo-3. Mitochondrial [Ca 2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy. CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca 2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca 2+] i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca 2+] i during P-MI was also prevented by ranolazine. CSE in clinically relevant concentrations increases myocyte [Ca 2+] i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</description><subject>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology</subject><subject>60 APPLIED LIFE SCIENCES</subject><subject>Acetanilides - pharmacology</subject><subject>Angina Pectoris - etiology</subject><subject>Angina Pectoris - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>CALCIUM</subject><subject>Calcium - metabolism</subject><subject>CALCIUM IONS</subject><subject>CARBON NITRIDES</subject><subject>Cells, Cultured</subject><subject>Cigarette smoke</subject><subject>CYANIDES</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>FLUORESCENCE</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>GLUCOSE</subject><subject>Glucose - metabolism</subject><subject>Heart Ventricles - drug effects</subject><subject>HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY</subject><subject>ISCHEMIA</subject><subject>Medical sciences</subject><subject>MICE</subject><subject>MITOCHONDRIA</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondrial Membrane Transport Proteins - drug effects</subject><subject>Mitochondrial Membrane Transport Proteins - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial Infarction - etiology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Ischemia - complications</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocyte</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>NICOTINE</subject><subject>Nicotine - analysis</subject><subject>OXIDATION</subject><subject>Piperazines - pharmacology</subject><subject>RABBITS</subject><subject>Ranolazine</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Smoke - adverse effects</subject><subject>Smoke - analysis</subject><subject>Smoking - adverse effects</subject><subject>Time Factors</subject><subject>TIRON</subject><subject>TOBACCO SMOKES</subject><subject>Tobacco, tobacco smoking</subject><subject>TOXICITY</subject><subject>Toxicology</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-P1DAMxSMEYoeFL8ABRUJw6-Ak3TaVuKDlr7QSF5C4RW7qQoa2GZLMaufb4zIjuHGKYv9s-b0nxFMFWwWqebXbFsT9VgN0W1BbAHtPbBR0TQXGmPtiA1CrisvfLsSjnHfAYF2rh-JCdaZVjVYbUd6GRL7IEu-ClzSO_MkyjhJ_HSgesqS7kpABLvnwHROVQjLP8SfJuEiPaQjo5XyM_lgoSyzST2EJHqfpKBNNdIsL1-LiaeFNJcQlPxYPRpwyPTm_l-Lr-3dfrj9WN58_fLp-c1P5ujalavrGeAW6B7JDra9so3rTtzg0Q4saWm7Z3htrx2646tvOAnYw1oNF6g2a1lyK56e9MZfgsg-F_A8-ZWGRTitlddt0TL08UfsUWXQubg7Z0zThsjrgNNSG7VpBfQJ9ijknGt0-hRnT0SlwayJu59ZE3JqIA-XYeh56dt5-6Gca_o2cI2DgxRnAzK6NCRcf8l9OK911tl251yeO2LHbQGkVRGzr8CdBN8Twvzt-A22nqvQ</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Yamada, Shigeyuki</creator><creator>Zhang, Xiu Quan</creator><creator>Kadono, Toshie</creator><creator>Matsuoka, Nobuhiro</creator><creator>Rollins, Douglas</creator><creator>Badger, Troy</creator><creator>Rodesch, Christopher K.</creator><creator>Barry, William H.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope></search><sort><creationdate>20090401</creationdate><title>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</title><author>Yamada, Shigeyuki ; Zhang, Xiu Quan ; Kadono, Toshie ; Matsuoka, Nobuhiro ; Rollins, Douglas ; Badger, Troy ; Rodesch, Christopher K. ; Barry, William H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-6b63c102b0e8d425861b3b7ad6d7a2071028bc388f9d5b7980a90f4d8aeb3a373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology</topic><topic>60 APPLIED LIFE SCIENCES</topic><topic>Acetanilides - pharmacology</topic><topic>Angina Pectoris - etiology</topic><topic>Angina Pectoris - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>CALCIUM</topic><topic>Calcium - metabolism</topic><topic>CALCIUM IONS</topic><topic>CARBON NITRIDES</topic><topic>Cells, Cultured</topic><topic>Cigarette smoke</topic><topic>CYANIDES</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>FLUORESCENCE</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>GLUCOSE</topic><topic>Glucose - metabolism</topic><topic>Heart Ventricles - drug effects</topic><topic>HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY</topic><topic>ISCHEMIA</topic><topic>Medical sciences</topic><topic>MICE</topic><topic>MITOCHONDRIA</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondrial Membrane Transport Proteins - drug effects</topic><topic>Mitochondrial Membrane Transport Proteins - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial Infarction - etiology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Ischemia - complications</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocyte</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>NICOTINE</topic><topic>Nicotine - analysis</topic><topic>OXIDATION</topic><topic>Piperazines - pharmacology</topic><topic>RABBITS</topic><topic>Ranolazine</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Smoke - adverse effects</topic><topic>Smoke - analysis</topic><topic>Smoking - adverse effects</topic><topic>Time Factors</topic><topic>TIRON</topic><topic>TOBACCO SMOKES</topic><topic>Tobacco, tobacco smoking</topic><topic>TOXICITY</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Shigeyuki</creatorcontrib><creatorcontrib>Zhang, Xiu Quan</creatorcontrib><creatorcontrib>Kadono, Toshie</creatorcontrib><creatorcontrib>Matsuoka, Nobuhiro</creatorcontrib><creatorcontrib>Rollins, Douglas</creatorcontrib><creatorcontrib>Badger, Troy</creatorcontrib><creatorcontrib>Rodesch, Christopher K.</creatorcontrib><creatorcontrib>Barry, William H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Shigeyuki</au><au>Zhang, Xiu Quan</au><au>Kadono, Toshie</au><au>Matsuoka, Nobuhiro</au><au>Rollins, Douglas</au><au>Badger, Troy</au><au>Rodesch, Christopher K.</au><au>Barry, William H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>236</volume><issue>1</issue><spage>71</spage><epage>77</epage><pages>71-77</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>Our goal was to determine if clinically relevant concentrations of aqueous extract of cigarette smoke (CSE) have direct deleterious effects on ventricular myocytes during simulated ischemia, and to investigate the mechanisms involved. CSE was prepared with a smoking chamber. Ischemia was simulated by metabolic inhibition (MI) with cyanide (CN) and 0 glucose. Adult rabbit and mouse ventricular myocyte [Ca 2+] i was measured by flow cytometry using fluo-3. Mitochondrial [Ca 2+] was measured with confocal microscopy, and Rhod-2 fluorescence. The mitochondrial permeability transition (MPT) was detected by TMRM fluorescence and myocyte contracture. Myocyte oxidative stress was quantified by dichlorofluorescein (DCF) fluorescence with confocal microscopy. CSE 0.1% increased myocyte contracture caused by MI. The nicotine concentration (HPLC) in 0.1% CSE was 15 ng/ml, similar to that in humans after smoking cigarettes. CSE 0.1% increased mitochondrial Ca 2+ uptake, and increased the susceptibility of mitochondria to the MPT. CSE 0.1% increased DCF fluorescence in isolated myocytes, and increased [Ca 2+] i in paced myocytes exposed to 2.0 mM CN, 0 glucose (P-MI). These effects were inhibited by the superoxide scavenger Tiron. The effect of CSE on [Ca 2+] i during P-MI was also prevented by ranolazine. CSE in clinically relevant concentrations increases myocyte [Ca 2+] i during simulated ischemia, and increases myocyte susceptibility to the MPT. These effects appear to be mediated at least in part by oxidative radicals in CSE, and likely contribute to the effects of cigarette smoke to increase myocardial infarct size, and to decrease angina threshold.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19371621</pmid><doi>10.1016/j.taap.2009.01.008</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2009-04, Vol.236 (1), p.71-77
issn 0041-008X
1096-0333
language eng
recordid cdi_osti_scitechconnect_21182769
source MEDLINE; Elsevier ScienceDirect Journals
subjects 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt - pharmacology
60 APPLIED LIFE SCIENCES
Acetanilides - pharmacology
Angina Pectoris - etiology
Angina Pectoris - metabolism
Animals
Biological and medical sciences
CALCIUM
Calcium - metabolism
CALCIUM IONS
CARBON NITRIDES
Cells, Cultured
Cigarette smoke
CYANIDES
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
FLUORESCENCE
Free Radical Scavengers - pharmacology
GLUCOSE
Glucose - metabolism
Heart Ventricles - drug effects
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
ISCHEMIA
Medical sciences
MICE
MITOCHONDRIA
Mitochondria, Heart - drug effects
Mitochondria, Heart - metabolism
Mitochondrial Membrane Transport Proteins - drug effects
Mitochondrial Membrane Transport Proteins - metabolism
Myocardial Contraction - drug effects
Myocardial Infarction - etiology
Myocardial Infarction - physiopathology
Myocardial Ischemia - complications
Myocardial Ischemia - metabolism
Myocardial Ischemia - physiopathology
Myocyte
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
NICOTINE
Nicotine - analysis
OXIDATION
Piperazines - pharmacology
RABBITS
Ranolazine
Reactive Oxygen Species - metabolism
Smoke - adverse effects
Smoke - analysis
Smoking - adverse effects
Time Factors
TIRON
TOBACCO SMOKES
Tobacco, tobacco smoking
TOXICITY
Toxicology
title Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A54%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20toxic%20effects%20of%20aqueous%20extract%20of%20cigarette%20smoke%20on%20cardiac%20myocytes%20at%20clinically%20relevant%20concentrations&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Yamada,%20Shigeyuki&rft.date=2009-04-01&rft.volume=236&rft.issue=1&rft.spage=71&rft.epage=77&rft.pages=71-77&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/j.taap.2009.01.008&rft_dat=%3Cproquest_osti_%3E20433719%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20433719&rft_id=info:pmid/19371621&rft_els_id=S0041008X09000283&rfr_iscdi=true